Structure via PubChem · Public domain (PubChem)
paliperidone
Sign in to saveAlso known as 9-hydroxyrisperidone, Invega®, Ro-76477, Ro-92670, Trevicta, 9-Hydroxyrisperidone
Paliperidone, sold under the brand name Invega among others, is an atypical antipsychotic. It is used for the treatment of schizophrenia and schizoaffective disorder. It is marketed by Janssen Pharmaceuticals.
Key facts
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 461753832
- Drug.image
- Paliperidone.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 250
- Drug.tradename
- Invega, others
- Drug.MedlinePlus
- a607005
- Drug.DailyMedID
- Paliperidone
- Drug.pregnancy_AU
- B3
- Drug.routes_of_administration
- By mouth, intramuscular
- Drug.class
- Atypical antipsychotic
- Drug.ATC_prefix
- N05
- Drug.ATC_suffix
- AX13
- Drug.legal_AU
- S4
- Drug.legal_BR
- C1
- Drug.legal_CA
- Rx-only
- Drug.legal_US
- Rx-only
via Wikipedia infobox
Chemical data
- Formula
- C23H27FN4O3
- Molecular weight
- 426.5 g/mol
- IUPAC name
- 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
- SMILES
- CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
- InChIKey
- PMXMIIMHBWHSKN-UHFFFAOYSA-N
- XLogP
- 2.2
- Polar surface area
- 82.2 Ų
- H-bond donors
- 1
- H-bond acceptors
- 7
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 2006
- Admin. routes
- oral
- Indications
- schizoaffective disorder, obsessive-compulsive disorder, psychosis, autism
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Has part
- carbon
- Mass
- 426.206719
- Has use
- medication
Show 7 more facts
- chemical formula
- C₂₃H₂₇FN₄O₃
- Commons category
- Paliperidone
- canonical SMILES
- CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
- medical condition treated
- mental disorder
- defined daily dose
- 2.5
- significant drug interaction
- tetrabenazine
- legal status (medicine)
- boxed warning
Sources (6)
via Wikidata · CC0
~7 min read
Encyclopedic overview
11 sectionsContents
- Medical use
- Adverse effects
- Pharmacology
- History
- Society and culture
- Deaths
- Suicides
- Homicides
- Brand names
- References
- External links
Paliperidone, sold under the brand name Invega among others, is an atypical antipsychotic. It is used for the treatment of schizophrenia and schizoaffective disorder. It is marketed by Janssen Pharmaceuticals.
Paliperidone was approved by the US Food and Drug Administration (FDA) for the treatment of schizophrenia in December 2006, and in the European Union in June 2007. Paliperidone palmitate is a long-acting injectable formulation of paliperidone palmitoyl ester. It is on the World Health Organization's List of Essential Medicines. Paliperidone is available as a generic medication.
Excerpted from Wikipedia’s “paliperidone” article, available under the CC BY-SA 4.0 licence.